Anna Porwit

Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part III – analytical issues

A. Porwit, T. Shankey, Shabnam Tangri, 2013, Cytometry. Part B, Clinical cytometry.

TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.

Eva Hellström-Lindberg, Brigitte Schlegelberger, Anette Hedlund, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

Wolfgang Kern, Jean Feuillard, Luca Malcovati, 2009, Haematologica.

Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern

Ingemar Ernberg, I. Ernberg, A. Porwit, 2007, Leukemia & lymphoma.

Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia

A. Porwit, M. Béné, Anna Porwit, 2019, Cytometry. Part B, Clinical cytometry.

Blood and Bone Marrow Pathology

Wendy N. Erber, A. Porwit, W. Erber, 2002 .